PRRT2 and urinary bladder cancer: Direct impact of TRIM29 is noticeable in bladder cancer, where Bcl family protein and cyclin D1/E levels are enhanced by TRIM29 through the PKC-NF-κB signaling pathway thus resulting in reduced apoptosis with an increase in proliferation signal [59].